Cargando…

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline

Cognitive dysfunctions such as mild cognitive impairment (MCI), Alzheimer’s disease (AD), and other forms of dementia are recognized as common comorbidities of type 2 diabetes mellitus (T2DM). Currently, there are no disease-modifying therapies or definitive clinical diagnostic and prognostic tools...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehtewish, Hanan, Arredouani, Abdelilah, El-Agnaf, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181591/ https://www.ncbi.nlm.nih.gov/pubmed/35682821 http://dx.doi.org/10.3390/ijms23116144

Ejemplares similares

Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study
por: Mesleh, Areej, et al.
Publicado: (2023)

High-throughput autoantibody screening identifies differentially abundant autoantibodies in autism spectrum disorder
por: Mesleh, Areej, et al.
Publicado: (2023)

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia
por: Ehtewish, Hanan, et al.
Publicado: (2023)

Identification of distinct circulating microRNAs in acute ischemic stroke patients with type 2 diabetes mellitus
por: Toor, Salman M., et al.
Publicado: (2022)

Greater and More Focused Measures Are Needed to Tackle Diabetes and Obesity Epidemics in the Nations of the Gulf Cooperation Council
por: Arredouani, Abdelilah
Publicado: (2021)

Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies
por: Zhao, Xue, et al.
Publicado: (2017)

Reduced odds of diabetes associated with high plasma salivary α-amylase activity in Qatari women: a cross-sectional study
por: Al-Akl, Neyla S., et al.
Publicado: (2021)

Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers
por: Khalifa, Olfa, et al.
Publicado: (2020)

Association of dyslipidemia, diabetes and metabolic syndrome with serum ferritin levels: a middle eastern population-based cross-sectional study
por: Al Akl, Neyla S., et al.
Publicado: (2021)

Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics
por: Bourgin, Mélanie, et al.
Publicado: (2023)

Lobar Cerebral Microbleeds Are Associated With Cognitive Decline in Patients With Type 2 Diabetes Mellitus
por: Shao, Pengfei, et al.
Publicado: (2022)

Diabetes Mellitus, Edentulism, and Trajectory of Cognitive Decline Among Older Adults
por: Wu, Bei, et al.
Publicado: (2021)

Exosomes in Age-Related Cognitive Decline: Mechanistic Insights and Improving Outcomes
por: Duggan, Michael R., et al.
Publicado: (2022)

circRNAs Signature as Potential Diagnostic and Prognostic Biomarker for Diabetes Mellitus and Related Cardiovascular Complications
por: Zaiou, Mohamed
Publicado: (2020)

Diabetes and cognitive decline: Challenges and future direction
por: Ab-Hamid, Norhamidar, et al.
Publicado: (2023)

The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights
por: Bohne, Loryn J., et al.
Publicado: (2019)

Elevated levels of salivary α- amylase activity in saliva associated with reduced odds of obesity in adult Qatari citizens: A cross-sectional study
por: Al-Akl, Neyla, et al.
Publicado: (2022)

High plasma salivary α-amylase, but not high AMY1 copy number, associated with low obesity rate in Qatari adults: cross-sectional study
por: Al-Akl, Neyla, et al.
Publicado: (2020)

Factors Associated with Cognitive Decline in Elderly Diabetics
por: Umegaki, Hiroyuki, et al.
Publicado: (2011)

Reversing Cognitive Decline in Aging: Reversible Mechanistic Defects and a Novel Nutritional Intervention
por: Sekhar, Rajagopal, et al.
Publicado: (2020)

CISD1 Is a Breast Cancer Prognostic Biomarker Associated with Diabetes Mellitus
por: Liu, Fangfang, et al.
Publicado: (2022)

Periphery Biomarkers for Objective Diagnosis of Cognitive Decline in Type 2 Diabetes Patients
por: Liu, Yanchao, et al.
Publicado: (2021)

Airway surface liquid volume expansion induces rapid changes in amiloride-sensitive Na(+) transport across upper airway epithelium-Implications concerning the resolution of pulmonary edema
por: Azizi, Fouad, et al.
Publicado: (2015)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Evaluating the Association between Diabetes, Cognitive Decline and Dementia
por: Ojo, Omorogieva, et al.
Publicado: (2015)

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline
por: Eliassen, Carl F., et al.
Publicado: (2017)

Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke
por: Aldous, Eman K., et al.
Publicado: (2022)

Autophagy Activation is Associated with Neuroprotection in Diabetes-associated Cognitive Decline
por: Wu, Yanqing, et al.
Publicado: (2019)

Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
por: Wu, Yuanyuan, et al.
Publicado: (2022)

Rhein for treating diabetes mellitus: A pharmacological and mechanistic overview
por: Deng, Tingting, et al.
Publicado: (2023)

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification
por: Mesleh, Areej G., et al.
Publicado: (2021)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

Discovering new peripheral plasma biomarkers to identify cognitive decline in type 2 diabetes
por: Yu, Haitao, et al.
Publicado: (2022)

Parkinson’s disease prognostic scores for progression of cognitive decline
por: Gramotnev, Galina, et al.
Publicado: (2019)

Changes in MEG resting-state networks are related to cognitive decline in type 1 diabetes mellitus patients
por: Demuru, Matteo, et al.
Publicado: (2014)

Temporal Speech Parameters Indicate Early Cognitive Decline in Elderly Patients With Type 2 Diabetes Mellitus
por: Imre, Nóra, et al.
Publicado: (2022)

Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients
por: Toor, Salman M., et al.
Publicado: (2022)

Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Resting state EEG biomarkers of cognitive decline associated with Alzheimer’s disease and mild cognitive impairment
por: Meghdadi, Amir H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdg00953jas4ivrad5uc2gucvq